Analysts expect over 2020 rising revenue Astrazeneca, huge dividend

Over the current book year the total revenue will be 26,6 billion GBp (consensus estimates). This is slightly more than 2019's revenue of 24,38 billion GBp.

Historical revenues and results Astrazeneca plus estimates 2020

koersdataAstrazeneca

The analysts expect for 2020 a net profit of 5,34 billion GBp. For this year the majority of the analysts, consulted by press agency Thomson Reuters, expects a profit per share of 394 GBp. The price-earnings-ratio equals 20,16.

Huge dividend Astrazeneca

Analysts expect a dividend of 279 GBp per share. The dividend yield is then 3,51 percent. The average dividend yield of the pharmaceutical companies is a poor 0,38 percent.

Astrazeneca's market capitalization is based on the number of outstanding shares around 10064,09 billion GBp. The Astrazeneca stock was the past 12 months quite volatile. Since last October the stock is 11 percent higher. This year the stock price moved between 5871 and 10120 GBp.

Historical stock prices Astrazeneca2007-2020

fundamental research astrazeneca

Click here for dividend Astrazeneca. On Monday the stock closed at 7943 GBp.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.